We are a team of French researchers that grew out of a university spin-off holding several patents in the field of molecular medicine. We have recently identified and isolated a gene that inhibits sensitivity to chemotherapy treatments of the intestinal tract; taking advantage of therapeutic magnetic nanoparticles, we have developed a diagnostic kit using this technology.
In order to enhance the value of this scientific finding, we are interested in productive engagement with a venture capitalist specialized in this field with an eye to collaboratively evaluating the best prospects for economic development.